TREATMENT OF MYOCARDIAL INFARCTION USING TGF-BETA ANTAGONISTS

Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-beta to the patient during the acute stage of...

Full description

Saved in:
Bibliographic Details
Main Authors GREGORY, RICHARD C. JR, LONNING, SCOTT, KUDEJ, AMELIA B, AKITA, GEOFFREY Y
Format Patent
LanguageEnglish
Polish
Published 31.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-beta to the patient during the acute stage of the myocardial infarction.
AbstractList Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse consequence of a myocardial infarction in a patient comprising administering an antagonist of TGF-beta to the patient during the acute stage of the myocardial infarction.
Author KUDEJ, AMELIA B
GREGORY, RICHARD C. JR
LONNING, SCOTT
AKITA, GEOFFREY Y
Author_xml – fullname: GREGORY, RICHARD C. JR
– fullname: LONNING, SCOTT
– fullname: KUDEJ, AMELIA B
– fullname: AKITA, GEOFFREY Y
BookMark eNrjYmDJy89L5WSwDQlydQzxdfULUfB3U_CN9Hd2DHLxdPRR8PRzcwxyDvH091MIDfb0c1cIcXfTdXINcVRw9AtxdPf38wwOCeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEBPkZmhoYWxoYhIcbGxKgBAFh_LC4
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate Leczenie zawału mięśnia sercowego z zastosowaniem antagonistów TGF-beta
ExternalDocumentID PL2611831TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_PL2611831TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 15:55:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Polish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_PL2611831TT33
Notes Application Number: PL20110758276T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190531&DB=EPODOC&CC=PL&NR=2611831T3
ParticipantIDs epo_espacenet_PL2611831TT3
PublicationCentury 2000
PublicationDate 20190531
PublicationDateYYYYMMDD 2019-05-31
PublicationDate_xml – month: 05
  year: 2019
  text: 20190531
  day: 31
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Genzyme Corporation
RelatedCompanies_xml – name: Genzyme Corporation
Score 3.2025065
Snippet Disclosed herein is a method of treating a patient suffering a myocardial infarction, particularly an acute myocardial infarction, or of reducing an adverse...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TREATMENT OF MYOCARDIAL INFARCTION USING TGF-BETA ANTAGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190531&DB=EPODOC&locale=&CC=PL&NR=2611831T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8NALMwp6ptOZc4PTpC-FWnXdfahyPVrm_SL7pT5NNbeDQayDVfx75ueq_qib8fdEXIhuSSXSwJwiya0PutbpsqL_F41uKWps7leqNziRSE0QxSya0kUm8Mn43HSmzRgUefCyDqhH7I4IkpUgfJeyvt6_fOI5cm_lZu7fIFTq4eA2Z6y9Y5RuyFPKZ5j-2niJa7iunYaKnFmo6OAzKux7g7sohXdlz7bs1Mlpax_a5TgCPZSBLYsj6Gxfm3BgVs3XmvBfrSNd-NwK3qbE7BZ5lNWld4nSUCil8SlmTeiIRnFAc3kVxBS9dAYEDYIVMdnlNCY0UESj8ZsfAo3gc_coYp4TL_PPE3DGmPW7Z5Bc7laijYQE_Uvmixc7_d0Q3A9F7o5NzSNzy3ca2jn0PkbTue_xQs4rOj3FRi_hGb59i6uUN-W-bWk1Cfp4n85
link.rule.ids 230,309,783,888,25577,76883
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8NALMwpzjedypxfJ0jfirTruvWhyK0fW7VfdKfMp7L2OhjINlzFv296buqLvh13R8iF5JJcLgnALZrQ6rRn6DLPs76scUORpzM1l7nB87xQtCIXXUuCUB89aQ-T7qQG820ujKgT-iGKI6JE5SjvpbivVz-PWLb4W7m-y-Y4tbx3mWlLG-8YtRvylGQPTCeO7MiSLMuMfSlMTHQUkHkV1tmBXbSw-8JTeh5USSmr3xrFPYS9GIEtyiOorV6b0LC2jdeasB9s4t043Ije-hhMljiUVaX3SeSS4CWyaGJ71Cde6NJEfAUhVQ-NIWFDVx44jBIaMjqMQm_Mxidw4zrMGsmIR_p95jT2txizTucU6ovlomgB0VH_osnC1V5X1QquZoWqzzRF4TMD92rKGbT_htP-b_EaGiMW-KnvhY_ncFDR8itIfgH18u29uETdW2ZXgmqfCQ2CKQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TREATMENT+OF+MYOCARDIAL+INFARCTION+USING+TGF-BETA+ANTAGONISTS&rft.inventor=GREGORY%2C+RICHARD+C.+JR&rft.inventor=LONNING%2C+SCOTT&rft.inventor=KUDEJ%2C+AMELIA+B&rft.inventor=AKITA%2C+GEOFFREY+Y&rft.date=2019-05-31&rft.externalDBID=T3&rft.externalDocID=PL2611831TT3